Iterating Toward Better Treatments for Pediatric Mood Disorders
Manpreet K. Singh, MD MS Associate Professor of Psychiatry and Behavioral Sciences Director, Stanford Pediatric Mood Disorders Program Akiko Yamazaki and Jerry Yang Faculty Scholar in Pediatric Translational Medicine, Stanford Maternal Child Health Research Institute, Stanford University
Research in early-onset mood disorders may be geared towards using neuroscience to develop interventions that alleviate symptoms, promote healthy brain development, and treat behavioral and emotional difficulties as soon as they arise.
Friday, February 19, 2021
9:00 am – 10:30 am ESTAdd to Cal
This webinar considers the promise of utilizing neuroscience tools to aim for reliable and lasting improvements in symptoms for a large number of children and adolescents who experience a broad spectrum of mood problems. The presentation considers the importance of understanding and leveraging the placebo effect and measuring mechanisms of change, both in the way that treatments are configured and in the way that future clinical trials are designed.
- Apply knowledge of how mood symptoms commonly present in youth, historical perspectives, and current state of neuroscience to guide us toward better evaluation of pediatric mood disorders.
- Utilize current neuroscience knowledge to guide us toward developing better treatments for pediatric mood disorders.
- Integrate knowledge from prior studies, including the placebo effect in pediatric depression clinical trials, to design new clinical trials.
About the Visiting Professor Lecture Series:
The Child Mind Institute Visiting Professor Lecture Series invites leaders in the field of child and adolescent mental health to talk about the latest research and treatment protocols. All events are open to the public. This year, all lectures will be hosted virtually over GoToWebinar. Continuing medical education (CME) credits for psychiatrists and continuing education (CE) credits for psychologists are through our partnership with Northwell Health.